Literature DB >> 21333385

Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial.

Dominique Pateron1, Eric Vicaut, Erwan Debuc, Karima Sahraoui, Nicolas Carbonell, Xavier Bobbia, Dominique Thabut, Frédéric Adnet, Pierre Nahon, Rolland Amathieu, Mounir Aout, Nicolas Javaud, Patrick Ray, Jean Claude Trinchet.   

Abstract

STUDY
OBJECTIVE: The quality of endoscopy depends on the quality of upper gastrointestinal tract preparation. We determine whether in acute upper gastrointestinal bleeding the frequency of satisfactory stomach visualization was different after intravenous erythromycin, a nasogastric tube with gastric lavage, or both.
METHODS: We performed a prospective, randomized, multicenter (6 emergency departments) study in patients with acute upper gastrointestinal bleeding presenting with hematemesis or melena. The patients were randomized into 3 groups: (1) intravenous erythromycin infusion without nasogastric tube placement (erythromycin group), (2) nasogastric tube placement without erythromycin (nasogastric group), and (3) intravenous erythromycin infusion combined with nasogastric tube placement (nasogastric-erythromycin group). The main outcome measure was the proportion of satisfactory stomach visualization.
RESULTS: Two hundred fifty-three patients (181 men, mean age 61 years [SD 15 years], 84 with cirrhosis) were randomized: 84 (erythromycin group), 85 (nasogastric group), and 84 (nasogastric-erythromycin group). Overall, there was 85% satisfactory stomach visualization; between-group differences were not significant: -4% (95% confidence interval [CI] -15% to 6%) for the erythromycin group and nasogastric-erythromycin group, 2% (95% CI -14% to 9%) for the erythromycin group and nasogastric group, and -6.5% (95% CI -17% to 4%) for the nasogastric group and nasogastric-erythromycin group. The duration of the endoscopic procedure, rebleeding frequency, the need for a second endoscopy, the number of transfused blood units, and mortality at days 2, 7, and 30 did not differ significantly between groups.
CONCLUSION: In acute upper gastrointestinal bleeding, administration of intravenous erythromycin provides satisfactory endoscopic conditions, without the need for a nasogastric tube and gastric lavage.
Copyright © 2011 American College of Emergency Physicians. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21333385     DOI: 10.1016/j.annemergmed.2011.01.001

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  13 in total

Review 1.  Pharmacologic options in the management of upper gastrointestinal bleeding: focus on the elderly.

Authors:  Moe Htet Kyaw; Francis Ka Leung Chan
Journal:  Drugs Aging       Date:  2014-05       Impact factor: 3.923

Review 2.  Diagnosis and management of nonvariceal upper gastrointestinal bleeding.

Authors:  Marc Bardou; Dalila Benhaberou-Brun; Isabelle Le Ray; Alan N Barkun
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-01-10       Impact factor: 46.802

3.  Predictive Factors for Endoscopic Visibility and Strategies for Pre-endoscopic Prokinetics Use in Patients with Upper Gastrointestinal Bleeding.

Authors:  Jun Uk Lim; Jae Jun Park; Young Hoon Youn; Sunyong Kim; Jung Won Jeon; Sung Won Jung; Hyun Phil Shin; Jae Myung Cha; Kwang Ro Joo; Joung Il Lee
Journal:  Dig Dis Sci       Date:  2014-10-18       Impact factor: 3.199

4.  Management by the intensivist of gastrointestinal bleeding in adults and children.

Authors:  David Osman; Michel Djibré; Daniel Da Silva; Cyril Goulenok
Journal:  Ann Intensive Care       Date:  2012-11-09       Impact factor: 6.925

5.  Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial.

Authors:  Hee Kyong Na; Hwoon-Yong Jung; Dong Woo Seo; Hyun Lim; Ji Yong Ahn; Jeong Hoon Lee; Do Hoon Kim; Kee Don Choi; Ho June Song; Gin Hyug Lee; Jin-Ho Kim
Journal:  Korean J Intern Med       Date:  2017-03-28       Impact factor: 2.884

6.  Prophylactic erythromycin in acute upper gastrointestinal bleeding: moving forward in improving endoscopic efficacy.

Authors:  Stephen Kim; V Raman Muthusamy
Journal:  Saudi J Gastroenterol       Date:  2013 Sep-Oct       Impact factor: 2.485

Review 7.  Pre-procedural Preparation and Sedation for Gastrointestinal Endoscopy in Patients with Advanced Liver Disease.

Authors:  Brian M Fung; Deanna J Leon; Lauren N Beck; James H Tabibian
Journal:  Dig Dis Sci       Date:  2021-06-24       Impact factor: 3.487

Review 8.  Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials.

Authors:  Shoba Theivanayagam; Roxanne G Lim; William J Cobell; Jayashree T Gowda; Michelle L Matteson; Abhishek Choudhary; Matthew L Bechtold
Journal:  Saudi J Gastroenterol       Date:  2013 Sep-Oct       Impact factor: 2.485

9.  Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding.

Authors:  Mohammad Javad Ehsani Ardakani; Ehsan Zare; Maryam Basiri; Hamid Mohaghegh Shalmani
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2013

10.  Pre-endoscopic erythromycin administration in upper gastrointestinal bleeding: an updated meta-analysis and systematic review.

Authors:  Rubayat Rahman; Douglas L Nguyen; Umair Sohail; Ashraf A Almashhrawi; Imran Ashraf; Srinivas R Puli; Matthew L Bechtold
Journal:  Ann Gastroenterol       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.